Assoc. Prof. MD.

İsmail Polat Canbolat

Cardiology

Ask Expert
Liv Hospital Vadistanbul
Interests

  • Hypertension
  • Heart Failure
  • Coronary Artery Disease
  • Coronary Angiography and Stent Procedures
  • Transcatheter Aortic Valve Implantation (TAVI)
  • Renal Denervation

3
h-index
Education:
  • Kadıköy Anatolian High School (2002)
  • Istanbul University Istanbul Faculty of Medicine (2008)
  • Istanbul University-Cerrahpaşa Cardiology Institute, Cardiology Residency (2013)
  • Demiroglu Bilim University Faculty of Medicine, Department of Cardiology Assistant Professor (2014-2020)
  • Demiroglu Bilim University Faculty of Medicine, Cardiology A.D. Assoc. Prof. Dr. (2020-2023)
Experience:
  • Liv Hospital Ulus
  • Istanbul Florence Nightingale Hospital (2020-2023)
  • Sisli Florence Nightingale Hospital (2014-2020)
  • Yüksekova State Hospital (2014)
  • Kağıthane State Hospital (2013-2014)
  • Belen E, Canbolat IP, Yiğittürk G, Çetinarslan Ö, Akdeniz CS, Karaca M, Sönmez M, Erbaş O.  Cardio-protective effect of dapagliflozin against doxorubicin induced cardiomyopathy in rats. European Review for Medical and Pharmacological Sciences 2022;26: 4403-4408
  • Süsleyici B, Çiftçi Ç, Yurdakul S, Çevik M, Akdeniz CS, Canbolat IP, Deliorman G, Karaalp A. Prevalence of CYP2C19 Polymorphisms in Clopidogrel Treated Turkish Patients: Preliminary Results. Current Pharmacogenomics and Personalized Medicine 2021; 18:116-122
  • Gezer E, Çevik M, Akdeniz CS, Canbolat IP, Yurdakul S, Sünbül M, Çağatay P, Deliorman G, Karaalp A, Çiftçi Ç, Süsleyici B. CYP3A4 1B Gene Polymorphism in Coronary Artery Disease Patients with Obesity Undergoing Statin Treatment. Current Pharmacogenomics and Personalized Medicine 2021; 18:18-23
  • Bezci K, Çevik M, Akdeniz CS, Canbolat IP, Yurdakul S, Sünbül M, Ataş H, Çağatay P, Çiftçi Ç, Karaalp A, Süsleyici B. Warfarin pharmacogenetics in patients with heart valve replacement. Gene Reports 2020; 20: https://doi.org/10.1016/j.genrep.2020.100769
  • Canbolat IP, Akdeniz C, Ferah O, Tokat Y. Postoperative N-terminal pro-brain natriuretic peptide predicts in-hospital mortality after living donor liver transplantation. Turk Kardiyol Dern. Ars. Ahead of Print DOI: 10.5543/tkda.2020.42637
  • Kalyoncuoglu M, Baskurt M, Kaya A, Dogan GM, Abaci O, Canbolat IP, Sinan UY, Kucukoglu S. Paraoxonase-1 enzyme activity and oxidative status in pulmonary hypertension. Bangladesh Journal of Medical Science 2020;19:652-58.
  • Canbolat IP, Adali G, CS Akdeniz, Bozkurt B, Ferah O, Bulutcu F, Yuzer Y, Tokat Y. Postoperative myocardial injury does not predict early and 1-year mortality after living donor liver transplantation. Transplant Proc. 2019;51:2478-81.
  • Usalp S, Demircan S, Yildiz O, Baskurt M, Kaplan O, Canbolat IP, Ciftci C, Yazicioglu N. Comparison of long-term follow-up in patients with single or dual chamber pacemakers: is downtrodden or take its rightful place? Gazz Med Ital - Arch Sci Med 2019;178:935-41. DOI: 10.23736/S0393-3660.18.04010-X
  • Sinan UY, Demir R, Canbolat IP, Palabıyık M, Kaya A, Kucukoglu MS. Pulmonary hypertension experience in an expert university hospital. Anatol J Cardiol. 2018;20(1):35‐40.
  • Canbolat IP, Erdogan Y, Adali G, Kaplan O, Dayangac M, Yuzer Y, Tokat Y. The predictive value of risk indices for cardiac complications in living donor liver transplantation. Bratisl Lek Listy 2018;119:289-93.
  • Canbolat IP, Belen E, Bayyigit A, Helvaci A, Kilickesmez K. Evaluation of daily blood pressure alteration in subclinical hypothyroidism. Acta Cardiol Sin. 2017;33:489–494
  • Elcioglu B, Sahin T, Yurdakul S, Canbolat IP, Aytekin S. Unexpected diagnosis in a liver donor candidate. Rev Port Cardiol. 2016;35:707-708
  • Belen E, Canbolat IP, Bayyigit A, Pusuroglu H, Helvaci A, Kilickesmez K. A new gap in the novel anticoagulants’ era: undertreatment. Blood Coagul Fibrinolysis Int J Haemost Thromb 2015;26:793–7.
  • Sinan UY, Canbolat IP, Baydar 0, Oktay V, Imre G, Kocas C, Abacı 0, Coskun U, Bostan C, Kilickesmez KO, Yildiz A, Kaya A, Gurmen T, Yigit Z. Relationship between increased serum resistin level and severity of coronary artery disease. Angiology. 2014;65:239–242
  • Bostan C, Sinan UY, Canbolat IP, Abaci 0, Munipoglu SK, Kucukoglu S. Factors predicting long-term mortality in patients with hypertrophic cardiomyopathy. Echocardiography 2014;31:1056‑61
  •  Bostan C, Sinan UY, Canbolat IP, Kucukoglu S. Cardiac amyloidosis cases with relative apical sparing of longitudinal strain Echocardiography 2014;31:241-4. 
  • Coskun U., Canbolat IP., Sinan UY., Bostan C., Kilickesmez K., Yildiz A., Baskurt M., Turan Cağlar FN., Hatemi A., Yildiz CE., Cöhcen S., Gurmen AT., Kucukoglu MS. Atypical chest X-Ray calcification in an idiopathic constrictive pericarditis case. Case Reports in Cardiology. 2013 ;2013:609610. DOI: 10.1155/2013/609610.
  • Başkurt M, Aktürk F, Keskin K, Canbolat IP, Karadag B, Kaya A, Yildiz A, Coskun U, Kilickesmez K, Esen O, Muniboglu SK. Serum high-sensitivity C-reactive protein, amyloid associated protein and N-terminal proBNP levels do not predict reversible myocardial ischaemia. Cardiovasc J Afr. 2011;22:85-9. 
  • Canbolat IP., Cavusoglu T., Yigitturk G., Ates U., Erbas O. The Protective Role of Resveratrol on Diabetic Cardiomyopathy. DOI: 10.1016/j.amjcard.2017.03.128
  • Serdar M Kucukoglu; Okay Abaci; Cüneyt Kocas; Kadriye Kiliçkesmez; ümit Y Sinan; Polat I Canbolat; Sinan üner. Relation of Complications to Phenotypic Characteristics in Bicuspid Aortic Valve Disease: A Single Center Experience Circulation.2013; 128: A17792
  • R.. Kaya, O. Baydar, U.Y. Sinan, I.P. Canbolat, C. Kocas, O. Abaci, S. Uner, M.S. Kucukoglu. Bicuspid aortic valve phenotype relationship with aortic root morphology and elasticity. ESC congress 2013, 31 Aug-4 Sep 2013, Amsterdam, Hollande.
  • S. Yigit, S. Sari, Canbolat IP, A. Arat Ozkan, MK. Ersanli, T. Gurmen Pentraxin-3 a novel biomarker for predicting coronary artery disease. ESC Congress 2013, 31 Aug-4 Sep 2013, Amsterdam, Hollande.
  • Turkish Society of Cardiology
  • European Society Of Cardiology
  • European Association of Percutaneous Cardiovascular Interventions
  • Pharmacogenomics and Individualized Treatment Association
  • Tennis Fencing Mountaineering Sports Club Association

Ask Liv Expert